| 866-843-4545
In this video we’re discussing brief information regarding the new d-o-t drug testing rule that went into effect on january 1st of 2018 there are multiple provisions of this new rule and we’ll discuss the pertinent information that employers need to be aware of the most significant portion of the new d-o-t rule is the expansion of the opiates panel to include
Oxycodone oxymorphone hydrocodone and hydromorphone some common names for the new semi-synthetic opioids include oxy cotton percodan percocet vicodin lortab norco dilaudid and excel go based on these new drugs being tested for employees should be instructed to visit with their prescribing physician to determine if they can be put on an alternative treatment or
Medication that does not render the d-o-t regulated employee medically unqualified under an applicable dod agency regulation or is likely to pose a significant safety risk as to trigger a reporting obligation by the mro to the employer the d-o-t drug testing panel is still a 5 panel drug test to include marijuana cocaine phencyclidine or pcp opioids to include
Codeine heroin morphine oxycodone oxymorphone hydrocodone and hydromorphone and amphetamines to include amphetamine methamphetamine and mdma and mda a major change in this new rule for the medical review officer is a timing of reporting a significant safety risk a laboratory positive drug tests may be overturned by the medical review officer when the employee has a
Verified legal prescription for a drug that caused the positive lab result when this occurs and the mro also has a safety concern the mro will report the negative result and also inform the employee to have their prescribing physician contact the mro within five days to determine if a non impairing effect drug or treatment can be prescribed so that the mro would
Not be required to make a safety concern or medically disqualified report to the employer the advice to do t regulated employees is to be proactive in dealing with the opiate prescription issues before being called for do t testing this is highly desirable to prevent potential job disqualification being temporarily removed from your position or potential job loss
For the d-o-t regulated employee do t regulated employers are advised to update their job descriptions to make the ability to operate in a constant state of alertness and safe manner an essential job duty and also to include a pre duty impairing effects prescription medications safety policy within their d-o-t policy this should also include medical marijuana as
An impairing effect substance as well even though it’s not acceptable as a legitimate medical excuse under do t do t drug testing policies should also be updated to reflect the new do t rule that went into effect on january 1st of 2018 national drug screening offers assistance with do t– drug and alcohol testing policies as well as policy updates
Transcribed from video
New DOT Rule (49 CFR Part 40) on Expanded Opiates in 4 Minutes By National Drug Screening
